PRMT5 Inhibition Drives Therapeutic Vulnerability to BCL-2 Inhibition with Venetoclax and Provides Rationale for Combination Therapy in Mantle Cell Lymphoma

被引：4
|
作者：
Brown, Fiona [1 ]
Zhang, Yang [2 ]
Hinterschied, Claire [1 ]
Prouty, Alexander [1 ]
Sloan, Shelby [3 ]
Helmig-Mason, JoBeth [3 ]
Chung, Ji Hyun [1 ]
Vaddi, Kris [2 ]
Chen-Kiang, Selina [4 ]
Di Liberto, Maurizio [4 ]
Alinari, Lapo [1 ]
Scherle, Peggy [2 ]
Lapalombella, Rosa [3 ]
Paik, Jihye [5 ]
Baiocchi, Robert A. [6 ]
机构：
[1] Ohio State Univ, Div Hematol, Dept Internal Med, Coll Med, Columbus, OH USA
[2] Prelude Therapeut, Wilmington, DE USA
[3] Ohio State Univ, Div Hematol, Dept Internal Med, Columbus, OH USA
[4] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA
[5] Cornell Univ, Paik Lab, New York, NY 10021 USA
[6] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
302
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA
    Liu, Yuchun
    Shen, Yongmei
    Qin, Chenhao
    Shi, Yizhen
    Rong, Guang
    Yu, Xilong
    ONCOLOGY REPORTS, 2013, 29 (01) : 244 - 252
  • [42] Inhibition of LINK-A lncRNA overcomes ibrutinib resistance in mantle cell lymphoma by regulating Akt/Bcl2 pathway
    Zhang, Ye
    Lu, Peng
    Zhou, Yan
    Zhang, Lifei
    PEERJ, 2021, 9
  • [43] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    Peirs, S.
    Frismantas, V.
    Matthijssens, F.
    Van Loocke, W.
    Pieters, T.
    Vandamme, N.
    Lintermans, B.
    Dobay, M. P.
    Berx, G.
    Poppe, B.
    Goossens, S.
    Bornhauser, B. C.
    Bourquin, J-P
    Van Vlierberghe, P.
    LEUKEMIA, 2017, 31 (10) : 2037 - 2047
  • [44] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
    S Peirs
    V Frismantas
    F Matthijssens
    W Van Loocke
    T Pieters
    N Vandamme
    B Lintermans
    M P Dobay
    G Berx
    B Poppe
    S Goossens
    B C Bornhauser
    J-P Bourquin
    P Van Vlierberghe
    Leukemia, 2017, 31 : 2037 - 2047
  • [45] Combined Inhibition of Protein Kinase CSNK2 and BET Proteins As a Novel Therapeutic Strategy for Mantle Cell Lymphoma
    Manni, Sabrina
    Saggin, Lara
    Pesavento, Maria
    Fregnani, Anna
    Tubi, Laura Quotti
    Danesin, Nicolo
    Scapinello, Greta
    Visentin, Andrea
    Zambello, Renato
    Vianello, Fabrizio
    Trentin, Livio
    Piazza, Francesco
    BLOOD, 2023, 142
  • [46] Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
    Bell, Hayden L.
    Blair, Helen J.
    Gosling, Samantha J. Jepson
    Galler, Martin
    Astley, Daniel
    Moorman, Anthony V.
    Heidenreich, Olaf
    Veal, Gareth J.
    van Delft, Frederik W.
    Lunec, John
    Irving, Julie A. E.
    LEUKEMIA, 2024, 38 (06) : 1223 - 1235
  • [47] The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2
    Sausville, EA
    CANCER RESEARCH, 1997, 57 (24) : 5610 - 5610
  • [48] The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2
    Palumbo, GA
    Yarom, N
    Gazit, A
    Sandalon, Z
    Baniyash, M
    KleinbergerDoron, N
    Levitzki, A
    BenYehuda, D
    CANCER RESEARCH, 1997, 57 (12) : 2434 - 2439
  • [49] Synthetic lethality of PRMT5 inhibition in NDRG2-deficient adult T-cell leukemia through HSP90A dysfunction
    Ichikawa, Tomonaga
    Shanab, Obeid
    Nakahata, Shingo
    Shimosaki, Shunsuke
    Manachai, Nawin
    Ono, Masaya
    Iha, Hidekatsu
    Shimoda, Kazuya
    Ismail, Mohammed
    Nassar, Ahmed
    Morishita, Kazuhiro
    CANCER SCIENCE, 2018, 109 : 40 - 40
  • [50] EGFR inhibition in combination with PI3K/AKT/mTOR and/or Bcl-2 inhibition is a promising novel therapeutic approach for inverted sinonasal papillomas and associated sinonasal carcinomas
    Apfel, Athena M.
    Qin, Zhaoping
    Liu, Albert
    Soellner, Matthew B.
    Merajver, Sofia D.
    Udager, Aaron M.
    Merrill, Nathan M.
    CANCER RESEARCH, 2022, 82 (12)
12345